References
- 1McMullin MF, Reilly JT, Campbell P, Bareford D, Green AR, Harrison CN, et al. Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosis. Br J Haematol. 2007; 138:821-2.1767288010.1111/j.1365-2141.2007.06741.xMcMullinMFReillyJTCampbellPBarefordDGreenARHarrisonCNet alAmendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosisBr J Haematol20071388212
- 2Passamonti F. How I treat polycythemia vera. Blood. 2012; 120:275-84.10.1182/blood-2012-02-36605422611155PassamontiFHow I treat polycythemia veraBlood201212027584
- 3Silver RT, Chow W, Orazi A, Arles SP, Goldsmith SJ. Evaluation of WHO criteria for diagnosis of polycythemia vera@Colon@ a prospective analysis. Blood. 2013; 122:1881-6.10.1182/blood-2013-06-50841623900239SilverRTChowWOraziAArlesSPGoldsmithSJEvaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysisBlood201312218816
- 4Roda P, Ferrari A, Tang X, Erlich P, Eisenhower C, Patel MD, et al. Determination of accuracy of polycythemia vera diagnoses and use of the JAK2V617F test in the diagnostic scheme. Ann Hematol. 2014; 93: 1467-72.10.1007/s00277-014-2068-224687383RodaPFerrariATangXErlichPEisenhowerCPatelMDet alDetermination of accuracy of polycythemia vera diagnoses and use of the JAK2V617F test in the diagnostic schemeAnn Hematol201493146772
- 5Hsu HC. Pathogenetic role of JAK2 V617F mutation in chronic myeloproliferative disorders. J Chin Med Assoc. 2007; 70:89-93.1738915210.1016/S1726-4901(09)70337-5HsuHCPathogenetic role of JAK2 V617F mutation in chronic myeloproliferative disordersJ Chin Med Assoc2007708993
- 6Usman M, Bilwani F, Kakepoto GN, Adil SN, Sajid R, Khurshid M. Polycythemia vera and idiopathic erythrocytosis@Colon@ comparison of clinical and laboratory parameters. J Pak Med Assoc. 2004; 54:249-51.15270182UsmanMBilwaniFKakepotoGNAdilSNSajidRKhurshidMPolycythemia vera and idiopathic erythrocytosis: comparison of clinical and laboratory parametersJ Pak Med Assoc20045424951
- 7Pietra D, Li S, Brisci A, Passamonti F, Rumi E, Theocharides A, et al. Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. Blood. 2008 111: 1686-9.17984312PietraDLiSBrisciAPassamontiFRumiETheocharidesAet alSomatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disordersBlood200811116869
- 8Geetha JP, Arathi CA, Shalini M, Srinivasa Murthy AG. JAK2 negative polycythemia vera. J Lab Physicians. 2010; 2:114-6.10.4103/0974-2727.7221521346910GeethaJPArathiCAShaliniMSrinivasa MurthyAGJAK2 negative polycythemia veraJ Lab Physicians201021146